Literature DB >> 16614988

An inverse correlation of human peripheral blood regulatory T cell frequency with the disease activity of ulcerative colitis.

Makoto Takahashi1, Kazuhiko Nakamura, Kuniomi Honda, Yousuke Kitamura, Takahiro Mizutani, Yuzuru Araki, Teppei Kabemura, Yoshiharu Chijiiwa, Naohiko Harada, Hajime Nawata.   

Abstract

Evidence suggests that CD4+CD25+ regulatory T cells play a crucial role in the suppression of intestinal inflammation. However, their role in the suppression of inflammatory bowel disease has not yet been addressed. We examined the proportion of regulatory T cells in inflammatory bowel disease. First, we isolated CD4+CD45RO+CD25+ T cells from the peripheral blood of healthy persons and showed that these cells suppressed T cell proliferation profoundly and expressed FoxP3 abundantly, revealing that they are regulatory cells. Then the proportion of CD45RO+CD25+ in peripheral blood CD4+ T cells was analyzed in patients and healthy controls by flow cytometry. CD4+CD45RO+CD25+ T cell frequency was significantly lower in active ulcerative colitis than in the control and inactive ulcerative colitis. CD4+CD45RO+CD25+ T cell frequency was inversely correlated with the clinical and endoscopic severity of ulcerative colitis. These results suggest that a deficiency of regulatory T cells is associated with the progression of ulcerative colitis.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16614988     DOI: 10.1007/s10620-006-3191-2

Source DB:  PubMed          Journal:  Dig Dis Sci        ISSN: 0163-2116            Impact factor:   3.199


  36 in total

1.  Thymus and autoimmunity: production of CD25+CD4+ naturally anergic and suppressive T cells as a key function of the thymus in maintaining immunologic self-tolerance.

Authors:  M Itoh; T Takahashi; N Sakaguchi; Y Kuniyasu; J Shimizu; F Otsuka; S Sakaguchi
Journal:  J Immunol       Date:  1999-05-01       Impact factor: 5.422

2.  CD4+CD25high regulatory cells in human peripheral blood.

Authors:  C Baecher-Allan; J A Brown; G J Freeman; D A Hafler
Journal:  J Immunol       Date:  2001-08-01       Impact factor: 5.422

3.  Coated mesalazine (5-aminosalicylic acid) versus sulphasalazine in the treatment of active ulcerative colitis: a randomised trial.

Authors:  D Rachmilewitz
Journal:  BMJ       Date:  1989-01-14

4.  Isolation and functional characterization of regulatory CD25brightCD4+ T cells from the target organ of patients with rheumatoid arthritis.

Authors:  Duojia Cao; Vivianne Malmström; Clare Baecher-Allan; David Hafler; Lars Klareskog; Christina Trollmo
Journal:  Eur J Immunol       Date:  2003-01       Impact factor: 5.532

5.  Foxp3 programs the development and function of CD4+CD25+ regulatory T cells.

Authors:  Jason D Fontenot; Marc A Gavin; Alexander Y Rudensky
Journal:  Nat Immunol       Date:  2003-03-03       Impact factor: 25.606

6.  CD4+CD25bright regulatory T cells actively regulate inflammation in the joints of patients with the remitting form of juvenile idiopathic arthritis.

Authors:  Ismé M de Kleer; Lucy R Wedderburn; Leonie S Taams; Alka Patel; Hemlata Varsani; Mark Klein; Wilco de Jager; Gisela Pugayung; Francesca Giannoni; Ger Rijkers; Salvatore Albani; Wietse Kuis; Berent Prakken
Journal:  J Immunol       Date:  2004-05-15       Impact factor: 5.422

7.  X-linked neonatal diabetes mellitus, enteropathy and endocrinopathy syndrome is the human equivalent of mouse scurfy.

Authors:  R S Wildin; F Ramsdell; J Peake; F Faravelli; J L Casanova; N Buist; E Levy-Lahad; M Mazzella; O Goulet; L Perroni; F D Bricarelli; G Byrne; M McEuen; S Proll; M Appleby; M E Brunkow
Journal:  Nat Genet       Date:  2001-01       Impact factor: 38.330

8.  Cytotoxic T lymphocyte-associated antigen 4 plays an essential role in the function of CD25(+)CD4(+) regulatory cells that control intestinal inflammation.

Authors:  S Read; V Malmström; F Powrie
Journal:  J Exp Med       Date:  2000-07-17       Impact factor: 14.307

9.  Human cd25(+)cd4(+) t regulatory cells suppress naive and memory T cell proliferation and can be expanded in vitro without loss of function.

Authors:  M K Levings; R Sangregorio; M G Roncarolo
Journal:  J Exp Med       Date:  2001-06-04       Impact factor: 14.307

10.  Cell contact-dependent immunosuppression by CD4(+)CD25(+) regulatory T cells is mediated by cell surface-bound transforming growth factor beta.

Authors:  K Nakamura; A Kitani; W Strober
Journal:  J Exp Med       Date:  2001-09-03       Impact factor: 14.307

View more
  41 in total

1.  T regulatory cells maintain intestinal homeostasis by suppressing γδ T cells.

Authors:  Sung-Gyoo Park; Ramkumar Mathur; Meixiao Long; Namiko Hosh; Liming Hao; Matthew S Hayden; Sankar Ghosh
Journal:  Immunity       Date:  2010-11-11       Impact factor: 31.745

2.  Regulatory T cells in patients with inflammatory bowel diseases treated with adacolumn granulocytapheresis.

Authors:  Emilio Cuadrado; Marta Alonso; Maria-Dolores de Juan; Pilar Echaniz; Juan-Ignacio Arenas
Journal:  World J Gastroenterol       Date:  2008-03-14       Impact factor: 5.742

3.  Diminution of Circulating CD4+CD25 high T cells in naïve Crohn's disease.

Authors:  Patrick Chamouard; Fanny Monneaux; Zoe Richert; Anne-Claire Voegeli; Thomas Lavaux; Marie Pierre Gaub; René Baumann; Pierre Oudet; Sylviane Muller
Journal:  Dig Dis Sci       Date:  2008-12-03       Impact factor: 3.199

Review 4.  The development and function of regulatory T cells.

Authors:  Creg J Workman; Andrea L Szymczak-Workman; Lauren W Collison; Meenu R Pillai; Dario A A Vignali
Journal:  Cell Mol Life Sci       Date:  2009-04-24       Impact factor: 9.261

Review 5.  Microbial activation of gut dendritic cells and the control of mucosal immunity.

Authors:  Jennifer L Owen; Mansour Mohamadzadeh
Journal:  J Interferon Cytokine Res       Date:  2013-08-20       Impact factor: 2.607

6.  Enhanced suppressive function of regulatory T cells from patients with immune-mediated diseases following successful ex vivo expansion.

Authors:  Tinghua Cao; Sally E Wenzel; William A Faubion; Gregory Harriman; Li Li
Journal:  Clin Immunol       Date:  2010-05-15       Impact factor: 3.969

Review 7.  Ulcerative colitis: immune function, tissue fibrosis and current therapeutic considerations.

Authors:  Jochen Maul; Martin Zeitz
Journal:  Langenbecks Arch Surg       Date:  2011-04-09       Impact factor: 3.445

Review 8.  Induced and natural regulatory T cells in the development of inflammatory bowel disease.

Authors:  Christopher G Mayne; Calvin B Williams
Journal:  Inflamm Bowel Dis       Date:  2013-07       Impact factor: 5.325

9.  Distinct roles of helper T-cell subsets in a systemic autoimmune disease.

Authors:  Katrina K Hoyer; Wilson F Kuswanto; Eugenio Gallo; Abul K Abbas
Journal:  Blood       Date:  2008-09-24       Impact factor: 22.113

10.  In situ patrolling of regulatory T cells is essential for protecting autoimmune exocrinopathy.

Authors:  Naozumi Ishimaru; Takeshi Nitta; Rieko Arakaki; Akiko Yamada; Martin Lipp; Yousuke Takahama; Yoshio Hayashi
Journal:  PLoS One       Date:  2010-01-05       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.